Terms: = Lymphoma AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
90 results:
1. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
Tischer-Zimmermann S; Bonifacius A; Santamorena MM; Mausberg P; Stoll S; Döring M; Kalinke U; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Front Immunol; 2023; 14():878953. PubMed ID: 37033971
[TBL] [Abstract] [Full Text] [Related]
2. Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
[TBL] [Abstract] [Full Text] [Related]
3. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
Kiamanesh Z; Ayati N; Sadeghi R; Hawkes E; Lee ST; Scott AM
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4661-4676. PubMed ID: 35932329
[TBL] [Abstract] [Full Text] [Related]
4. B-Lymphoblastic Leukemia With Aberrant CD5 Expression.
Ye MT; Zhu J; Luo DX; Wang Y; Chen Z; Yang Y; Tian C; Zhang Y; You MJ
Am J Clin Pathol; 2021 Sep; 156(4):586-595. PubMed ID: 33822875
[TBL] [Abstract] [Full Text] [Related]
5. CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
Sekiguchi N; Komatsu M; Ichiyama T; Kobayashi A; Gomi D; Fukushima T; Kobayashi T; Noguchi T; Nakazawa H; Asano N; Ishida F; Koizumi T
J Int Med Res; 2021 Feb; 49(2):300060521996165. PubMed ID: 33641488
[TBL] [Abstract] [Full Text] [Related]
6. Improving Therapeutic cd20 Antibodies Requires Insight into Their Mechanism of Action.
Arp AB; Elfrink S; van Spriel AB
Crit Rev Oncog; 2020; 25(3):251-273. PubMed ID: 33463945
[TBL] [Abstract] [Full Text] [Related]
7. Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab.
Felberg A; Taszner M; Urban A; Majeranowski A; Jaskuła K; Jurkiewicz A; Stasiłojć G; Blom AM; Zaucha JM; Okrój M
Front Immunol; 2020; 11():584509. PubMed ID: 33329558
[TBL] [Abstract] [Full Text] [Related]
8. Tumorous formation of the forehead.
Temelkova I; Tchernev G
Wien Med Wochenschr; 2020 May; 170(7-8):196-198. PubMed ID: 31993874
[TBL] [Abstract] [Full Text] [Related]
9. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
[TBL] [Abstract] [Full Text] [Related]
10. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract] [Full Text] [Related]
11. Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.
Erbe AK; Wang W; Carmichael L; Hoefges A; Grzywacz B; Reville PK; Ranheim EA; Hank JA; Kim K; Seo S; Mendonca EA; Song Y; Kenkre VP; Hong F; Gascoyne RD; Paietta E; Horning SJ; Miller JS; Kahl B; Sondel PM
J Immunother Cancer; 2019 Mar; 7(1):70. PubMed ID: 30871628
[TBL] [Abstract] [Full Text] [Related]
12. Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy.
Jamois C; Gibiansky E; Gibiansky L; Buchheit V; Sahin D; Cartron G; Marcus R; Hiddemann W; Seymour JF; Strefford JC; Hargreaves CE; Meneses-Lorente G; Frey N; Fingerle-Rowson G
Br J Clin Pharmacol; 2019 Jul; 85(7):1495-1506. PubMed ID: 30866056
[TBL] [Abstract] [Full Text] [Related]
13. Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell lymphoma: An Analysis of 7051 Cases in the SEER Database.
Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
[TBL] [Abstract] [Full Text] [Related]
15. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
[TBL] [Abstract] [Full Text] [Related]
16. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
[TBL] [Abstract] [Full Text] [Related]
17. Rituximab in the management of acute lymphoblastic leukemia.
Levato L; Molica S
Expert Opin Biol Ther; 2018 Feb; 18(2):221-226. PubMed ID: 29310477
[TBL] [Abstract] [Full Text] [Related]
18. Novel Insights into Membrane Targeting of B Cell lymphoma.
de Winde CM; Elfrink S; van Spriel AB
Trends Cancer; 2017 Jun; 3(6):442-453. PubMed ID: 28718418
[TBL] [Abstract] [Full Text] [Related]
19. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.
Cruz-Rodriguez N; Combita AL; Enciso LJ; Raney LF; Pinzon PL; Lozano OC; Campos AM; Peñaloza N; Solano J; Herrera MV; Zabaleta J; Quijano S
J Exp Clin Cancer Res; 2017 Feb; 36(1):37. PubMed ID: 28245840
[TBL] [Abstract] [Full Text] [Related]
[Next]
